Europe
Initial focus on diagnosing infectious disease through development of machine-free, lab-quality, True Point-of-Care™ products
MorphoSys AG announced the end of the clinical development program of MOR106 in atopic dermatitis.
Free Lonza webinar to discuss the benefits of a collaborative approach to implementing an Electronic Batch Record Platform
This marks the eighth such extension for the deal.
The companies indicate that the decision was based on lack of efficacy, not any safety concerns.
BioMed X announced the successful completion of their first research collaboration project with AbbVie in the field of tau-mediated neurodegeneration in Alzheimer’s disease.
Rentschler Biopharma SE, a world-class contract development and manufacturing organization for biopharmaceuticals, announced that its Chairman of the Board, Prof. Dr. Nikolaus F. Rentschler, together with CEO Dr. Frank Mathias have received the “EY Entrepreneur of the Year” Award 2019 in the category Industry.
Edan Diagnostics, Inc., a wholly own subsidiary of Edan Instruments, Inc., a world leader in the development and manufacture of bio-electronic devices and laboratory analyzers for medical diagnostics, and LGC, a global life science tools leader, announced today the sale of LGC’s ClariLight molecular diagnostics POC platform to Edan.
CELLINK has announced the opening of an office in Lyon, France to strengthen their relationships with customers locally and throughout Europe.
The Society for Medical Decision Making awarded Regenstrief Institute researcher Stephen Downs, M.D., M.S., with the John M. Eisenberg Award for Practical Application of Medical Decision Making Research.
PRESS RELEASES